LTS Lohmann Therapie-Systeme AG
4 products found
LTS Lohmann Therapie-Systeme AG products
LTS - Transdermal Therapeutic Systems for Improved Outcomes
LTS Lohmann Therapie-Systeme AG specializes in transdermal therapeutic systems (TTS) that enhance patient outcomes by ensuring controlled and balanced drug release, reducing peak concentrations, and mitigating common side effects such as nausea and vomiting. These systems provide a non-invasive delivery route, suitable for active substances with low oral bioavailability, ensuring improved efficacy and conservation of expensive materials. The TTS innovations accommodate individual market positioning and lifecycle management of established products. They are well-suited for patients with special needs, including those with Parkinson’s disease, and are particularly beneficial for children, older adults, and patients with complex care requirements due to easier application and reduced dosage intervals. Moreover, these systems can support enhanced patient compliance by minimizing interruptions, especially with multi-day patches, even for patients facing difficulty swallowing conventional oral dosages.
LTS - Oral Thin Films for Fast Drug Delivery
Oral thin film (OTF) technologies are designed to facilitate rapid drug delivery by placing the film on or under the tongue or buccally. The film quickly dissolves, allowing the active ingredient to be absorbed directly through the oral mucosa into the bloodstream. Ranging in size from 2 to 10 cm² and with thicknesses of 20 to 500 µm, these films offer a range of benefits. They enable fast onset of action, can improve bioavailability by circumventing the first-pass effect, and provide a convenient alternative to injectable medications. This technology is particularly beneficial for patients who experience difficulty swallowing, including those with conditions such as Multiple Sclerosis or ALS. The customizable release profiles of the drugs in OTF form add flexibility for pharmaceutical partners while enhancing compliance and convenience for patients. These films are easier for children, the elderly, and those requiring complex care, offering a discreet and water-free method of administration, ideal for use on the go.
LTS - MAP - Microneedle Technology for Pharmaceuticals
LTS Lohmann Therapie-Systeme AG provides Microneedle Array Patches (MAP), a microneedle technology offering potential advantages for the delivery of existing vaccines such as influenza, tetanus toxoid, measles-rubella, and Hepatitis B, as well as biologics and small molecules. This innovation allows a pain-free, safe application with options for fast onset and sustained release. Customizable in design, the MAPs can simplify healthcare logistics by potentially eliminating the need for cold chain storage, reducing healthcare costs, and avoiding needlestick injuries. They enable self-administration, which could lower healthcare expenses and increase patient compliance, particularly for those with needlestick phobias or difficulty swallowing. The technology is particularly beneficial for patient groups such as children, older adults, and those requiring complex care.